Arm Holdings is answering a fresh round of European Union antitrust questions about how it packages CPU blueprints with newer GPU and security IP, according to people familiar with the review, reopening scrutiny of the Cambridge company’s licensing model just two years after its Nasdaq listing. Commission officials want to know whether device makers must accept bundled access to latest-generation extensions if they want performance cores for flagship phones—a structure rivals say raises switching costs for Qualcomm, MediaTek, and Samsung’s internal silicon teams.
What regulators are probing
The inquiry follows complaints from chip designers who allege Arm shifted from per-family royalties to portfolio deals that tie Cortex CPU licenses to Immortalis GPU blocks and TrustZone firmware updates. EU case teams sent questionnaires this month asking for copies of master agreements, discount schedules, and any clauses that penalize customers who ship non-Arm graphics in the same SoC. Arm has publicly described its offerings as optional tiers; complainants argue that flagship-tier access is effectively mandatory if vendors want timely core updates.
Brussels can impose fines or demand contract changes if it finds abuse of dominance. Arm’s market share in mobile CPU IP remains above ninety percent by unit volume, giving enforcers a high bar to prove harm but also a wide footprint to remedy.
Why London cares
Although the probe sits with the Commission, UK competition officials still monitor Arm because its headquarters and primary R&D campus remain in Cambridge. The Competition and Markets Authority’s earlier work on Nvidia’s abandoned takeover created a public record of licensing concerns from Apple, Qualcomm, and automotive customers. Ministers cited those filings when arguing Arm should stay neutral as a supplier to the whole ecosystem.
FTSE watchers note Arm’s ADR listing means EU remedies could hit revenue recognized in dollars while engineering jobs stay in Britain. Trade associations asked DSIT whether UK firms caught in EU production chains would face conflicting royalty caps; the department has not published guidance.
Arm’s response
In regulatory filings Arm repeats that customers choose which compute subsystems to license and that it publishes roadmaps years ahead. Spokespeople declined to comment on the confidential questionnaires but pointed to investor presentations showing growing revenue from subscription-style “Arm Total Access” deals. The company argues those contracts reduce legal overhead for OEMs juggling dozens of core variants.
Legal teams are preparing data rooms with version histories for the Armv9 architecture, hoping to show that older cores remain available without GPU bundles for mid-range devices. They must also explain firmware support timelines—an area where phone makers say delayed security patches once forced unplanned respins.
Customer stakes
Handset OEMs worry that prolonged investigations freeze negotiation leverage. A European remedy mandating unbundling could lower bill-of-materials costs on premium Android flagships, but might also slow unified roadmaps if GPU and CPU teams no longer share validation labs. Server startups building Arm-based racks for European cloud regions said they support scrutiny so long as it does not delay export licenses for datacenter parts already qualified under US rules.
Automotive buyers, still ramping Cortex-R deployments for driver-assist chips, asked the Commission to separate mobile GPU complaints from safety-critical cores so factory toolchains are not disrupted.
Timeline and parallels
Commission probes of this type often run twelve to eighteen months before a statement of objections or closure. Lawyers compare the file to earlier EU reviews of Qualcomm’s patent licensing, though Arm’s model sells blueprints rather than finished modems. US Federal Trade Commission staff have monitored Arm since the Nvidia deal collapsed but have not announced a parallel formal order.
For British policymakers, the case is a test of whether post-Brexit Britain can influence global chip rules when the company at the center remains domestically rooted but sells worldwide. Arm must file initial answers by late October; until then, customers are likely to avoid signing wide-ranging portfolio renewals that could be reopened if Brussels orders renegotiation.
Investor watch
SoftBank-backed shareholders will parse any Commission language on royalty caps because licensing revenue funds the majority of Arm’s operating margin. Analysts do not expect near-term earnings hits, but contract uncertainty could weigh on guidance if renewals slip into 2027.
